Halozyme Therapeutics HALO is scheduled to report fourth-quarter and full-year 2024 results on Feb. 18, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback